Okada R D, Leppo J A, Boucher C A, Pohost G M
J Clin Invest. 1982 Jan;69(1):199-209. doi: 10.1172/jci110431.
The purpose of the present study was to define myocardial and blood thallium-201 (Tl-201) kinetics after infusion of dipyridamole in normal canine myocardium and in myocardium distal to a coronary artery stenosis. Miniature radiation detector probes were implanted in the left ventricle in 39 open-chest dogs. A balloon constrictor was placed around the proximal left circumflex coronary artery. Electromagnetic flow probes were positioned proximally around both the left circumflex and left anterior descending coronary arteries. In five control dogs (group 1) the balloon occluder was not inflated; in 12 dogs (group 2) a mild stenosis was created such that resting flow was not reduced, yet the hyperemic response after 10 s of total occlusion was partially attenuated; in nine dogs (group 3) a moderate stenosis was created such that resting flow was not reduced, yet the hyperemic response was completely eliminated; and in 13 dogs (group 4) a severe stenosis was created such that resting flow was reduced. After intravenous dipyridamole (0.08 mg/kg . min-1 x 4 min), 1.5 mCi Tl-201 was injected intravenously and probe counts were collected continuously for 4 h. The mean 4-h fractional myocardial Tl-201 clearance for nonstenotic zones was 0.35, 0.27 for group 2 stenotic zones, 0.19 for group 3 stenotic zones, and 0.05 for group 4 stenotic zones (P less than 0.0001). After reaching peak activity, myocardial Tl-201 activity cleared biexponentially with a final decay constant lambda 2 = 0.0017 +/- 0.0001 min-1 (SE) for nonstenotic zones, 0.0011 +/- 0.0001 min-1 for group 2 stenotic zones, and 0.0006 +/- 0.0001 min-1 for group 3 stenotic zones (P less than 0.01). Group 4 stenotic zone Tl-201 clearances were negligible (decay constant essentially zero). Blood Tl-201 activity decayed triexponentially with a final blood lambda 3 = 0.0018 +/- 0.0001 min-1, which was almost identical to the final myocardial lambda 2 decay constant. Thus, the rate of myocardial Tl-201 clearance can distinguish between coronary stenoses of graded hemodynamic severity. These results may be applicable to quantitative techniques for determining myocardial Tl-201 clearance rates on serial clinical images after dipyridamole administration.
本研究的目的是确定在正常犬心肌以及冠状动脉狭窄远端心肌中输注双嘧达莫后心肌和血液中铊-201(Tl-201)的动力学变化。在39只开胸犬的左心室内植入微型辐射探测器探头。在左回旋支冠状动脉近端放置一个球囊缩窄器。电磁流量探头分别置于左回旋支和左前降支冠状动脉近端。5只对照犬(第1组)球囊封堵器未充气;12只犬(第2组)造成轻度狭窄,静息血流未减少,但完全闭塞10秒后的充血反应部分减弱;9只犬(第3组)造成中度狭窄,静息血流未减少,但充血反应完全消失;13只犬(第4组)造成重度狭窄,静息血流减少。静脉注射双嘧达莫(0.08mg/kg·min-1×4分钟)后,静脉注射1.5mCi Tl-201,并连续收集探头计数4小时。非狭窄区域4小时心肌Tl-201平均清除分数为0.35,第2组狭窄区域为0.27,第3组狭窄区域为0.19,第4组狭窄区域为0.05(P<0.0001)。达到峰值活性后,心肌Tl-201活性呈双指数清除,非狭窄区域最终衰减常数λ2=0.0017±0.0001min-1(标准误),第2组狭窄区域为0.0011±0.0001min-1,第3组狭窄区域为0.0006±0.0001min-1(P<0.01)。第4组狭窄区域Tl-201清除率可忽略不计(衰减常数基本为零)。血液中Tl-201活性呈三指数衰减,最终血液λ3=0.0018±0.0001min-1,几乎与最终心肌λ2衰减常数相同。因此,心肌Tl-201清除率可区分不同血流动力学严重程度的冠状动脉狭窄。这些结果可能适用于在双嘧达莫给药后通过系列临床图像测定心肌Tl-201清除率的定量技术。